Implantable Collamer Lens Market Outlook Shows USD 1.3 Billion Target by 2035
The global Implantable Collamer Lens (ICL) market is poised for transformational growth—expanding from USD 0.4 billion in 2025 to USD 1.3 billion by 2035 , at a projected CAGR of 13.1% . This momentum highlights a decade of accelerated adoption, innovation, and manufacturing advancement across ophthalmic technology sectors. As manufacturers navigate the evolving medical device landscape, the ICL industry presents a unique opportunity for innovation-driven companies to meet rising patient and practitioner demand for next-generation, minimally invasive vision correction solutions. Rising Global Need for Advanced Vision Correction Refractive errors such as myopia, hyperopia, and astigmatism continue to surge globally—driven by lifestyle changes, increased screen exposure, and demographic trends. The myopia segment , accounting for 61.7% of market share in 2025 , dominates the ICL space due to its effectiveness in correcting moderate-to-high re...